intravenous NEDD8-activating enzyme inhibitor

Ph. III candidate for oncology

from HTS and optimization

Drug Metab. Dispos.

Takeda, Lexington, MA

Pevonedistat Chemical Structure, intravenous NEDD8-activating enzyme inhibitor - Takeda, Lexington, MA

Context. Pevonedistat (Takeda) is a first-in-class intravenous or subcutaneous NEDD8-activating enzyme (NAE) inhibitor being developed for leukemia and advanced solid tumors. NAE is a pivotal regulator of the NEDD8…

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: